Glucose Suppression of Glucagon Secretion: Metabolic and Calcium Responses from Alpha-cells in Intact Mouse Pancreatic Islets
Overview
Authors
Affiliations
Glucagon is released from alpha-cells present in intact pancreatic islets at glucose concentrations below 4 mm, whereas higher glucose levels inhibit its secretion. The mechanisms underlying the suppression of alpha-cell secretory activity are poorly understood, but two general types of models have been proposed as follows: direct inhibition by glucose or paracrine inhibition from non-alpha-cells within the islet of Langerhans. To identify alpha-cells for analysis, we utilized transgenic mice expressing fluorescent proteins targeted specifically to these cells. Measurements of glucagon secretion from pure populations of flow-sorted alpha-cells show that contrary to its effect on intact islets, glucose does stimulate glucagon secretion from isolated alpha-cells. This observation argues against a direct inhibition of glucagon secretion by glucose and supports the paracrine inhibition model. Imaging of cellular metabolism by two-photon excitation of NAD(P)H autofluorescence indicates that glucose is metabolized in alpha-cells and that glucokinase is the likely rate-limiting step in this process. Imaging calcium dynamics of alpha-cells in intact islets reveals that inhibiting concentrations of glucose increase the intracellular calcium concentration and the frequency of alpha-cell calcium oscillations. Application of candidate paracrine inhibitors leads to reduced glucagon secretion but did not decrease the alpha-cell calcium activity. Taken together, the data suggest that suppression occurs downstream from alpha-cell calcium signaling, presumably at the level of vesicle trafficking or exocytotic machinery.
Islet hormones at the intersection of glucose and amino acid metabolism.
White P, Wewer Albrechtsen N, Campbell J Nat Rev Endocrinol. 2025; .
PMID: 40055529 DOI: 10.1038/s41574-025-01100-4.
The role of mu-opioid receptors in pancreatic islet α-cells.
Kong C, Castro D, Lee J, Piston D J Mol Endocrinol. 2024; 74(1).
PMID: 39475846 PMC: 11875080. DOI: 10.1530/JME-24-0060.
Acreman S, Ma J, Denwood G, Gao R, Tarasov A, Rorsman P iScience. 2024; 27(5):109665.
PMID: 38646167 PMC: 11033163. DOI: 10.1016/j.isci.2024.109665.
Urocortin 3 contributes to paracrine inhibition of islet alpha cells in mice.
Noguchi G, Castillo V, Donaldson C, Flisher M, Momen A, Saghatelian A J Endocrinol. 2024; 261(3).
PMID: 38593829 PMC: 11095665. DOI: 10.1530/JOE-24-0018.
Deng J, Luo K, Xia C, Zhu Y, Xiang Z, Zhu B Heliyon. 2024; 10(5):e27145.
PMID: 38468973 PMC: 10926077. DOI: 10.1016/j.heliyon.2024.e27145.